Nigeria launches Genomic City backed by planned $500m fund
Nigeria has announced a Genomic City initiative at the University of Abuja, backed by a planned $500 million annual research fund, to commercialize biotechnology and attract domestic and foreign investment.
The Nigerian government has launched the Nigeria Genomic City, a multi-agency project anchored at the University of Abuja aimed at building a commercial hub for genomics, biotechnology and precision medicine. Conceived over 20 months ago, the initiative is designed to operate as a national economic asset.
Financing for the broader ecosystem is taking shape through a planned National Research and Innovation Development Fund. Education Minister Dr Maruf Tunji Alausa said enabling legislation for the fund, which is expected to mobilise about $500 million annually, is currently awaiting necessary approvals.
For market participants, the project signals a deliberate shift from basic research toward the commercialisation of health and agricultural technologies. A dedicated focus on data sovereignty and intellectual property frameworks suggests an effort to ensure domestic capture of value from genomic resources. “The biggest demographic dividend ever witnessed anywhere in the world could become a demographic calamity for us if we fail to act. We do not have a choice,” Alausa said, stressing the urgency of the project.
The commercial applications span multiple sectors. In healthcare, the platform will support the development of solutions for disease prevention, diagnosis and treatment. In agriculture, genomic science will be deployed to improve crop and livestock yields, directly addressing food security constraints.
The government intends to integrate artificial intelligence and bioinformatics into the city's operations. Professor Mayowa Owolabi, Pioneer Director of the Centre for Genomic and Precision Medicine at the University of Ibadan, stated the infrastructure is built to attract investment from both domestic and international sources.
Developing a highly skilled scientific workforce is a core component of the strategy, essential for sustaining a complex biotech ecosystem. The multi-ministerial approach reflects the scale of the infrastructure required to make Nigeria competitive in precision medicine.
Implementation will be coordinated by the Federal Ministry of Education, with NITDA and the National Board for Technology Incubation providing technological support. The initiative builds on existing frameworks, including a cancer research programme launched last year. That effort, overseen by the National Institute for Cancer Research and Treatment's Director-General Prof. Usman Aliyu, is currently training 120 young researchers.
